Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
We noticed you are on our US page. Want to switch regions? Choose from the options:
UK
AU
ES
Find a location
Find a doctor
Make an inquiry
Refer a patient
Healthcare Professionals
Latest research
Publications
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer
15 Oct 2020
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer
Written by
Shore Neal D., MD, FACS
Zhang T, Harrison MR, O'Donnell PH, Alva AS, Hahn NM, Appleman LJ, Cetnar J, Burke JM, Fleming MT, Milowsky MI, Mortazavi A, Sonpavde GP, Schmidt EV, Bitman B, Munugalavadla V, Izumi R, Patel P, Staats J, Chan C, Weinhold KJ, George DJ
Back to top
